Skip to main content

Table 1 Patient characteristics (N = 53)

From: A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma

Characteristics

No.of patients (%)

Age (years)

 Median

59

 Range

42-73

Gender

 Male

46 (87.8)

 Female

7 (13.2)

Histology

 Squamous

50 (94.3)

 Adenocarcinoma

3 (5.7)

Tumor location of newly diagnosed

33 (62.2)

 Cervical

2 (3.8)

 Upper thoracic

7 (13.2)

 Middle thoracic

9 (17.0)

 Lower thoracic

9 (17.0)

 Synchronous multiple primary

6 (11.3)

ECOG a score

 0-1

48 (90.6)

 2

5 (9.4)

Stage (UICC b 6 th edition)

 Newly diagnosed

33 (62.2)

 T4NxM0

9 (17.0)

 T2-3NxM0-1

17 (32.0)

 T4NxM1

7 (13.2)

 Postoperative LNMc

20 (37.7)

Planned dose of radiation

 61.2 Gy

41 (77.4)

 50.4 Gy

12 (22.6)

  1. aEastern Cooperative Oncology Group; bUnion for International Cancer Control; Clymph node metastasis